Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
JAMA Psychiatry. 2020 Nov 1;77(11):1155-1162. doi: 10.1001/jamapsychiatry.2020.1689.
Responding to the opioid crisis requires tools to identify individuals at risk of overdose. Given the expansion of illicit opioid deaths, it is essential to consider risk factors across multiple service systems.
To develop a predictive risk model to identify opioid overdose using linked clinical and criminal justice data.
DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional sample was created using 2015 data from 4 Maryland databases: all-payer hospital discharges, the prescription drug monitoring program (PDMP), public-sector specialty behavioral treatment, and criminal justice records for property or drug-associated offenses. Maryland adults aged 18 to 80 years with records in any of 4 databases were included, excluding individuals who died in 2015 or had a non-Maryland zip code. Logistic regression models were estimated separately for risk of fatal and nonfatal opioid overdose in 2016. Model performance was assessed using bootstrapping. Data analysis took place from February 2018 to November 2019.
Controlled substance prescription fills and hospital, specialty behavioral health, or criminal justice encounters.
Fatal opioid overdose defined by the state medical examiner and 1 or more nonfatal overdoses treated in Maryland hospitals during 2016.
There were 2 294 707 total individuals in the sample, of whom 42.3% were male (n = 970 019) and 53.0% were younger than 50 years (647 083 [28.2%] aged 18-34 years and 568 160 [24.8%] aged 35-49 years). In 2016, 1204 individuals (0.05%) in the sample experienced fatal opioid overdose and 8430 (0.37%) experienced nonfatal opioid overdose. In adjusted analysis, the factors mostly strongly associated with fatal overdose were male sex (odds ratio [OR], 2.40 [95% CI, 2.08-2.76]), diagnosis of opioid use disorder in a hospital (OR, 2.93 [95% CI, 2.17-3.80]), release from prison in 2015 (OR, 4.23 [95% CI, 2.10-7.11]), and receiving opioid addiction treatment with medication (OR, 2.81 [95% CI, 2.20-3.86]). Similar associations were found for nonfatal overdose. The area under the curve for fatal overdose was 0.82 for a model with hospital variables, 0.86 for a model with both PDMP and hospital variables, and 0.89 for a model that further added behavioral health and criminal justice variables. For nonfatal overdose, the area under the curve using all variables was 0.85.
In this analysis, fatal and nonfatal opioid overdose could be accurately predicted with linked administrative databases. Hospital encounter data had higher predictive utility than PDMP data. Model performance was meaningfully improved by adding PDMP records. Predictive models using linked databases can be used to target large-scale public health programs.
应对阿片类药物危机需要工具来识别有过量用药风险的个体。鉴于非法阿片类药物死亡人数的增加,必须考虑跨多个服务系统的风险因素。
开发一种使用关联的临床和刑事司法数据来识别阿片类药物过量的预测风险模型。
设计、地点和参与者:使用马里兰州的 4 个数据库中的 2015 年数据创建了一个横截面样本:所有支付者医院出院、处方药物监测计划 (PDMP)、公共部门专科行为治疗和与财产或药物相关的犯罪记录。纳入马里兰州 18 至 80 岁有 4 个数据库中记录的成年人,不包括 2015 年死亡或非马里兰州邮政编码的个体。分别为 2016 年的致命和非致命阿片类药物过量风险估计了逻辑回归模型。使用自举法评估模型性能。数据分析于 2018 年 2 月至 2019 年 11 月进行。
受控物质处方配药和医院、专科行为健康或刑事司法遭遇。
州法医定义的致命阿片类药物过量和 2016 年在马里兰州医院治疗的 1 次或多次非致命过量。
样本中共有 2294707 人,其中 42.3%为男性(n=970019),53.0%年龄小于 50 岁(647083[28.2%]年龄 18-34 岁,568160[24.8%]年龄 35-49 岁)。在 2016 年,样本中有 1204 人(0.05%)经历了致命的阿片类药物过量,8430 人(0.37%)经历了非致命的阿片类药物过量。在调整分析中,与致命过量最密切相关的因素是男性(比值比 [OR],2.40 [95% CI,2.08-2.76])、在医院诊断为阿片类药物使用障碍(OR,2.93 [95% CI,2.17-3.80])、2015 年从监狱获释(OR,4.23 [95% CI,2.10-7.11])和接受药物成瘾治疗(OR,2.81 [95% CI,2.20-3.86])。非致命过量也存在类似的关联。致命过量的曲线下面积为 0.82,用于具有医院变量的模型;0.86,用于具有 PDMP 和医院变量的模型;进一步添加行为健康和刑事司法变量的模型为 0.89。对于非致命的过量,使用所有变量的曲线下面积为 0.85。
在这项分析中,致命和非致命的阿片类药物过量可以通过关联的行政数据库准确预测。医院就诊数据比 PDMP 数据具有更高的预测能力。通过添加 PDMP 记录,模型性能得到了显著提高。使用关联数据库的预测模型可用于针对大规模公共卫生计划。